IP Verse

Glp-1 Receptor Agonists And Uses Thereof

Patent No. EP3555064 (titled "Glp-1 Receptor Agonists And Uses Thereof") was filed by Pfizer on Dec 1, 2017. The application was issued on Mar 1, 2023.

Patent Summary

Patent Family

Patent Family

Patent Oppositions

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentative
MARGARET DIXONAug 23, 2023ELKINGTON AND FIFE

Dossier Documents

The dossier documents provide a comprehensive record of the patent's prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent's legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents

EP3555064

PFIZER
Application Number
EP17817174A
Filing Date
Dec 1, 2017
Status
Granted And Under Opposition
Oct 21, 2022
Publication Date
Mar 1, 2023
External Links
Slate, Register , Google Patents